The ventrolateral preoptic nucleus is not required for isoflurane general anesthesia

被引:33
作者
Eikermann, Matthias [2 ,3 ,4 ]
Vetrivelan, Ramalingam [1 ,2 ]
Grosse-Sundrup, Martina [1 ,2 ,3 ]
Henry, Mark E. [1 ,2 ]
Hoffmann, Ulrike [1 ,2 ]
Yokota, Shigefumi [1 ,2 ,5 ]
Saper, Clifford B. [1 ,2 ]
Chamberlin, Nancy L. [1 ,2 ]
机构
[1] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Massachusetts Gen Hosp, Dept Anesthesia, Boston, MA 02114 USA
[4] Univ Klinikum Essen, Klin Anasthesie & Intens Med, Essen, Germany
[5] Shimane Univ, Sch Med, Dept Anat & Morphol Neurosci, Izumo, Shimane 6938501, Japan
关键词
Hypothalamus; Isoflurane; Rat; Sleep; Sleep deprivation; EYE-MOVEMENT SLEEP; RIGHTING REFLEX; BASAL FOREBRAIN; ADENOSINE; NEURONS; DEPRIVATION; ACTIVATION; RECEPTORS; PATHWAYS; STATE;
D O I
10.1016/j.brainres.2011.10.018
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neurons of the ventrolateral preoptic nucleus (VLPO) promote sleep and VLPO loss produces insomnia. Previous studies show that general anesthetics including isoflurane activate VLPO neurons, and may contribute to their sedative effects. However, it is not clear to what extent the activation of VLPO neurons contributes to general anesthesia. We tested whether destruction of the VLPO neurons would affect the onset, depth, or recovery from isoflurane's general anesthetic effects. The VLPO was ablated in 25 rats by bilateral local injection of orexin-saporin, and polysomnography was performed to measure baseline sleep loss and responses to isoflurane anesthesia at 1% and 2%. Eight rats received sham (saline) injections. We measured isoflurane effects on time to loss of righting reflex, onset of continuous slow wave activity, and burst suppression; burst-suppression ratio; and time to recovery of righting reflex and desynchronized EEG. VLPO neuron cell loss was quantified by post hoc histology. Loss of VLPO neurons as well as lesion size were associated with cumulative sleep loss (r=0.77 and r=0.62, respectively), and cumulative sleep loss was the strongest predictor of high sensitivity to anesthesia, expressed as decreased time to loss of righting reflex (-0.59), increased burst-suppression ratio (r=0.52), and increased emergence time (r=0.54); an interaction-effect of isoflurane dose was observed (burst-suppression ratio: p<0.001). We conclude that the sleep loss caused by ablation of VLPO neurons sensitizes animals to the general anesthetic effects of isoflurane, but that the sedation produced by VLPO neurons themselves is not required for isoflurane anesthesia. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:30 / 37
页数:8
相关论文
共 26 条
[1]   Adenosine inhibits basal forebrain cholinergic and noncholinergic neurons in vitro [J].
Arrigoni, E. ;
Chamberlin, N. L. ;
Saper, C. B. ;
McCarley, R. W. .
NEUROSCIENCE, 2006, 140 (02) :403-413
[2]   Adenosine mediation of presynaptic feedback inhibition of glutamate release [J].
Brambilla, D ;
Chapman, D ;
Greene, R .
NEURON, 2005, 46 (02) :275-283
[3]   Effects of adenosine on gabaergic synaptic inputs to identified ventrolateral preoptic neurons [J].
Chamberlin, NL ;
Arrigoni, E ;
Chou, TC ;
Scammell, TE ;
Greene, RW ;
Saper, CB .
NEUROSCIENCE, 2003, 119 (04) :913-918
[4]  
Chou TC, 2003, J NEUROSCI, V23, P10691
[5]   Pentobarbital Dose-dependently increases Respiratory Genioglossus Muscle Activity while Impairing Diaphragmatic Function in Anesthetized Rats [J].
Eikermann, Matthias ;
Fassbender, Philipp ;
Zaremba, Sebastian ;
Jordan, Amy S. ;
Rosow, Carl ;
Malhotra, Atul ;
Chamberlin, Nancy L. .
ANESTHESIOLOGY, 2009, 110 (06) :1327-1334
[6]  
Evers A S., 2006, Clinical Anesthesia, P111
[7]   General anaesthesia: From molecular targets to neuronal pathways of sleep and arousal [J].
Franks, Nicholas P. .
NATURE REVIEWS NEUROSCIENCE, 2008, 9 (05) :370-386
[8]   Reassessment of the Structural Basis of the Ascending Arousal System [J].
Fuller, Patrick ;
Sherman, David ;
Pedersen, Nigel P. ;
Saper, Clifford B. ;
Lu, Jun .
JOURNAL OF COMPARATIVE NEUROLOGY, 2011, 519 (05) :933-956
[9]  
KALES A, 1968, ELECTROEN CLIN NEURO, V24, P397
[10]  
KAY DC, 1972, CLIN PHARMACOL THER, V13, P221